|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||

* Department of Microbiology, University of Alabama, Birmingham, AL 35294-2170
Department of Medicine, University of California, Los Angeles, CA 90095-1679
Published, JLR Papers in Press, April 16, 2005. DOI 10.1194/jlr.M500085-JLR200
1 To whom correspondence should be addressed. e-mail: janusz{at}uab.edu
Lysophosphatidylcholine (LPC) is considered a major proatherogenic component of oxidized low density lipoprotein based on its proinflammatory actions in vitro. LPC stimulates macrophage and T-cell chemotaxis via the G protein-coupled receptor G2A and may thus promote inflammatory cell infiltration during atherosclerotic lesion development. However, G2A also mediates proapoptotic effects of LPC and may therefore promote the death of inflammatory cells within developing lesions. To determine how these effects of LPC modify atherogenesis, we examined atherosclerotic lesion development in G2A-sufficient and G2A-deficient low density lipoprotein receptor knockout mice. Although LPC species capable of activating G2A-dependent responses were increased during lesion development, G2A-deficient mice developed lesions similar in size to those in their G2A-sufficient counterparts. Loss of G2A during atherosclerotic lesion development did not reduce macrophage and T-cell infiltration but instead resulted in increased lesional macrophage content associated with reduced numbers of terminal deoxynucleotidyl transferase-mediated dUTP nick end labeled cells and decreased collagen deposition.
These data indicate that the ability of LPC to stimulate macrophage and T-cell chemotaxis via G2A is not manifested in vivo and that G2A-mediated proapoptotic rather than chemotactic action is most penetrant during atherogenesis and may modify the stability of atherosclerotic lesions by promoting macrophage death.
Abbreviations: ESI-MS/MS, electrospray ionization-tandem mass spectrometry; FCS, fetal calf serum; GPCR, G protein-coupled receptor; GPR4, G protein-coupled receptor 4; LDLR/, low density lipoprotein receptor knockout; LPC, lysophosphatidylcholine; MPO, myeloperoxidase; OGR1, ovarian cancer G protein-coupled receptor 1; OxLDL, oxidized low density lipoprotein; PAF-AH, platelet-activating factor-acetylhydrolase; TDAG8, T-cell death-associated gene 8; TUNEL, terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling
Supplementary key words atherosclerosis lysophosphatidylcholine T cells chemotaxis apoptosis
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
S. C. Frasch, K. Zemski-Berry, R. C. Murphy, N. Borregaard, P. M. Henson, and D. L. Bratton Lysophospholipids of Different Classes Mobilize Neutrophil Secretory Vesicles and Induce Redundant Signaling through G2A J. Immunol., May 15, 2007; 178(10): 6540 - 6548. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. T. Bolick, A. M. Whetzel, M. Skaflen, T. L. Deem, J. Lee, and C. C. Hedrick Absence of the G Protein-Coupled Receptor G2A in Mice Promotes Monocyte/Endothelial Interactions in Aorta Circ. Res., March 2, 2007; 100(4): 572 - 580. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. W. Parks, A. J. Lusis, and J. H.S. Kabarowski Loss of the Lysophosphatidylcholine Effector, G2A, Ameliorates Aortic Atherosclerosis in Low-Density Lipoprotein Receptor Knockout Mice Arterioscler. Thromb. Vasc. Biol., December 1, 2006; 26(12): 2703 - 2709. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Namgaladze and B. Brune Phospholipase A2-Modified Low-Density Lipoprotein Activates the Phosphatidylinositol 3-Kinase-Akt Pathway and Increases Cell Survival in Monocytic Cells Arterioscler. Thromb. Vasc. Biol., November 1, 2006; 26(11): 2510 - 2516. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Journal of Biological Chemistry |
| Molecular and Cellular Proteomics | ASBMB Today |